# FDA 483 - LifeSouth Community Blood Centers Inc - January 07, 2026

Source: https://www.keypedia.com/records/483/lifesouth-community-blood-centers-inc/2314bd46-2d5f-4b8e-8250-f4177dbafd5e

> FDA 483 for LifeSouth Community Blood Centers Inc on January 07, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: LifeSouth Community Blood Centers Inc
- Inspection Date: 2026-01-07
- Product Type: biologics
- Office Name: FDA District Office — Atlanta, Georgia
- Summary: LifeSouth Community Blood Centers Inc, a donor center in Valdosta, GA, was cited for failing to consistently follow its written standard operating procedures for handling temperature excursions of stored blood and blood components. The inspection revealed multiple instances in both 2024 and 2025 where staff did not properly evaluate temperature alarms or report deviations as required by their internal procedures. This indicates a lapse in adherence to established quality control processes for critical materials.

## Related Officers

- [Steven D. Banks](https://www.keypedia.com/people/steven-d-banks/30e4d016-e386-423d-9df8-1536cf43a0a3)

Company: https://www.keypedia.com/companies/lifesouth-community-blood-centers-inc/3067c476-77a5-4598-90eb-c61e98443d32

Office: https://www.keypedia.com/offices/fda-district-office-atlanta-georgia/bae3b8c4-4161-4e9f-b5d1-e0e80b6abd43